Results 151 to 160 of about 2,198 (193)

Systemic therapies for medullary thyroid carcinoma: state of the art. [PDF]

Ther Adv Endocrinol Metab
Román-González A, Califano I, Concepción-Zavaleta M, Pitoia F, Salgado SA.   +4 more
europepmc   +1 more source

Identification of alkynyl nicotinamide HSN748 as a RET solvent-front mutant inhibitor with intracranial efficacy. [PDF]

RSC Med Chem
Khatri U, Dayal N, Owusu KB, Hunjan MK, Pandey S, Harper HA, McMahan C, Elzey BD, Shen T, Hu X, Evans KW, El-Sheikh A, Jo SJ, Holtsberg FW, Aman MJ, Meric-Bernstam F, Woo S, Sintim HO, Wu J.   +18 more
europepmc   +1 more source

An emerging melody composed of the notes from structural variants - Comment on 'The fusion characteristics of RET fusion in pan-cancer among the Chinese population: A comprehensive genomic analysis' by Chen et al. [PDF]

Transl Oncol
Wu L, Zhou Q, Lu C.
europepmc   +1 more source

Mechanisms of resistance to RET-directed therapies. [PDF]

Endocr Relat Cancer
Clifton-Bligh RJ.
europepmc   +1 more source

Successful treatment with selpercatinib after pralsetinib-related pneumonitis and intracranial failure in a patient with RET-rearranged nonsmall cell lung cancer

Valeria Cognigni, Giulia Claire Giudice, Francesca Bozzetti, Gianluca Milanese, Ilaria Moschini, Massimiliano Casali, Giulia Mazzaschi, Marcello Tiseo   +7 more
openalex   +1 more source

Discovery of an orally bioavailable, CNS active pan-mutant RET kinase heterobifunctional degrader. [PDF]

RSC Med Chem
Orsi DL, Lazarski KE, Improgo R, Agafonov RV, Ahn JY, Baddour J, Cassidy K, Chaturvedi P, Cole KS, Deibler RW, Elam WA, Fitzgerald ME, Garza VJ, Good A, Hulton CH, Isasa M, Jackson KL, Li P, Liang Y, Michael RE, O'Shea MW, Moustakim M, Perino S, Rahman F, Schnaderbeck MJ, Stone NP, Tillotson B, Veits GK, Vogelaar A, Yap JL, Yu RT, Huang H, Henderson JA.   +32 more
europepmc   +1 more source

RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and Future. [PDF]

Drugs
Chen MF, Repetto M, Wilhelm C, Drilon A.
europepmc   +1 more source

Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs". [PDF]

Cancers (Basel)
Spitaleri G, Trillo Aliaga P, Attili I, Del Signore E, Corvaja C, Pellizzari G, Katrini J, Passaro A, de Marinis F.   +8 more
europepmc   +1 more source

Multidisciplinary team diagnosis and treatment of well-differentiated thyroid carcinoma: current landscape and future prospects. [PDF]

Oncologist
Li Y, Wang P, Cao J, Liu H.
europepmc   +1 more source